Kirsch A J, Oz M C, Stoopler M, Ginsburg M, Steinglass K
Department of Urology, Columbia University, College of Physicians and Surgeons, New York, New York.
Urology. 1993 Dec;42(6):716-9. doi: 10.1016/0090-4295(93)90542-i.
Most surgeons consider patients with solitary adrenal metastasis from a primary lung carcinoma incurable and avoid excision of both the adrenal and primary lung tumors. However, several cases of successful surgical management of these patients recently have been reported. We reviewed 12 surgically treated patients with isolated adrenal and lung disease and identified 2 survivors of greater than fifteen years (17%) and 4 additional patients who are still alive following combined resection (34%). This survival rate, albeit in a selected population, represents an improvement over the natural history of nine months' survival. We suggest that if after six to twelve months of following patients with lung cancer and isolated adrenal metastasis no other evidence of spread of disease is evident, the tumor biology may be favorable and resection of both adrenal and lung lesions is reasonable.
大多数外科医生认为,原发性肺癌伴有孤立性肾上腺转移的患者无法治愈,因此避免切除肾上腺和原发性肺部肿瘤。然而,最近有几例对这些患者成功进行手术治疗的病例报道。我们回顾了12例接受手术治疗的孤立性肾上腺和肺部疾病患者,确定了2例存活超过15年的患者(17%),另有4例患者在联合切除术后仍然存活(34%)。尽管这是一个特定人群,但这种生存率相较于自然病程九个月的生存率有所提高。我们建议,如果在对肺癌合并孤立性肾上腺转移的患者进行六至十二个月的随访后,没有其他疾病扩散的证据,那么肿瘤生物学特性可能较好,切除肾上腺和肺部病变是合理的。